Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 21.18B | 25.01B | 20.56B | 21.99B | 15.00B |
Gross Profit | 5.99B | 6.60B | 5.54B | 5.52B | 4.35B |
EBITDA | 1.37B | 2.42B | 1.74B | 1.88B | 2.12B |
Net Income | 805.58M | 1.01B | 452.33M | 643.26M | 544.46M |
Balance Sheet | |||||
Total Assets | 19.65B | 19.16B | 18.65B | 18.09B | 16.83B |
Cash, Cash Equivalents and Short-Term Investments | 1.35B | 1.11B | 762.96M | 681.75M | 1.66B |
Total Debt | 5.96B | 5.62B | 5.62B | 4.12B | 3.08B |
Total Liabilities | 7.27B | 6.99B | 6.78B | 5.35B | 4.81B |
Stockholders Equity | 12.43B | 12.20B | 11.89B | 12.75B | 12.02B |
Cash Flow | |||||
Free Cash Flow | 1.56B | 1.71B | -396.95M | -1.18B | 2.05B |
Operating Cash Flow | 1.78B | 2.16B | 9.40M | -732.41M | 2.31B |
Investing Cash Flow | -175.15M | -437.82M | -373.96M | -432.47M | -135.31M |
Financing Cash Flow | -1.34B | -1.39B | 456.08M | 151.75M | -1.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $12.62B | 11.48 | 8.44% | 10.30% | -4.33% | -19.79% | |
78 Outperform | $3.92B | 13.72 | 4.99% | 1.73% | 8.44% | -14.06% | |
76 Outperform | HK$138.90B | 22.93 | 22.73% | 2.94% | -17.53% | -8.90% | |
75 Outperform | HK$5.60B | 7.00 | 6.25% | 8.69% | -15.34% | -20.36% | |
57 Neutral | HK$25.53B | 4.08 | -2.03% | 6.14% | -0.31% | -67.64% | |
47 Neutral | HK$2.27B | ― | 0.28% | ― | -69.05% | 34.94% | |
43 Neutral | $1.87B | 62.16 | -6.53% | ― | -8.30% | -661.54% |
Chow Sang Sang Holdings International Limited has announced the composition of its Board of Directors, which includes both executive and non-executive members, as well as independent non-executive directors. The company has also detailed the membership of its three Board committees: the Audit Committee, the Remuneration Committee, and the Nomination Committee. This announcement provides clarity on the leadership structure and governance of the company, which could influence stakeholder confidence and the company’s strategic direction.
The most recent analyst rating on (HK:0116) stock is a Buy with a HK$14.80 price target. To see the full list of analyst forecasts on Chow Sang Sang Holdings International stock, see the HK:0116 Stock Forecast page.
Chow Sang Sang Holdings International Limited announced the passing of Mr. Chung Pui Lam, a Non-executive Director and a member of several key committees, on July 3, 2025. Mr. Chung had been a significant contributor to the company for 30 years, and his passing is a notable loss for the company’s leadership and governance structure.
The most recent analyst rating on (HK:0116) stock is a Buy with a HK$14.80 price target. To see the full list of analyst forecasts on Chow Sang Sang Holdings International stock, see the HK:0116 Stock Forecast page.
Chow Sang Sang Holdings International Limited has updated the terms of reference for its Nomination Committee, which is responsible for reviewing the board’s composition and making recommendations on director appointments. The committee’s duties include proposing evaluation criteria for directorship candidates, reviewing board structure, and supporting board diversity. This update aims to enhance the company’s governance and align board composition with corporate strategy, potentially impacting its strategic direction and stakeholder interests.
The most recent analyst rating on (HK:0116) stock is a Buy with a HK$14.80 price target. To see the full list of analyst forecasts on Chow Sang Sang Holdings International stock, see the HK:0116 Stock Forecast page.
Chow Sang Sang Holdings International Limited announced that all proposed resolutions at their Annual General Meeting on May 27, 2025, were approved by shareholders. These resolutions included the adoption of financial statements, declaration of dividends, re-election of directors, and granting mandates for share repurchase and issuance. The successful passing of these resolutions reflects strong shareholder support and positions the company for continued operational stability and strategic growth.
The most recent analyst rating on (HK:0116) stock is a Buy with a HK$14.80 price target. To see the full list of analyst forecasts on Chow Sang Sang Holdings International stock, see the HK:0116 Stock Forecast page.
Chow Sang Sang Holdings International Limited has announced its upcoming annual general meeting scheduled for May 27, 2025. Key agenda items include the adoption of financial statements, declaration of a final dividend, re-election of directors, and authorization of director remuneration. Additionally, the company seeks approval for share repurchase and issuance powers, which could impact its capital structure and shareholder value.